Trial Profile
A Prospective, Open, Uncontrolled, Observational Study With Innolet in Daily Clinical Situations According to the Product Labelling, Without Any Study Specific Investigations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 11 Apr 2012 Actual number of patients changed from 1034 to 1030 as reported by ClinicalTrials.gov.
- 19 Dec 2011 New trial record